Our Regenerative Medicine Platform

Arbor Life Labs has developed and patented a regenerative medicine platform that regulates Wnt/Beta-Catenin to activate stem cells to proliferate and differentiate into tissue cells. Our platform also targets the regulation of multiple pathways to promote homeostasis and thereby healthy functioning cells, tissues and organs. Our technology can be formulated to regulate any or all of the following pathways: GF-7, FGF-18, HGF, IGF, KGF, VEGF, BMP, mTORC1, PKC, PPARγ, Shh, Wnt/Beta-Catenin, COX, INF-α, ING-γ, Interleukins, NF-κB, Prostaglandins, TNF-α, TGF-β,  5α-Reductase.